Assistance Publique Hôpitaux de Marseille-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2023

  1. Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial

    JAMA Oncology, Vol. 9, Núm. 12, pp. 1688-1695